Related Experiment Video
Updated: Jan 16, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Matricellular Proteins (MCPs) in Rheumatoid Arthritis
Asiya Kurmanova1, Dieter Riethmacher1
1Department of Biomedical Sciences, School of Medicine, Nazarbayev University, 01000, Astana, Kazakhstan.
Matricellular proteins are implicated in rheumatoid arthritis (RA) pathogenesis, influencing inflammation and disease progression. Further research into these proteins may reveal new diagnostic and therapeutic strategies for RA.
Area of Science:
- Immunology
- Biochemistry
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease impacting joints and potentially other organs.
- RA affects women twice as often as men, causing significant patient distress and societal costs.
- Disease development involves complex cellular pathways like JAK-STAT, MAPK, PI3K/AKT, and Wnt signaling, leading to cytokine and matrix metalloproteinase production.
Purpose of the Study:
- To review current research on the roles of matricellular proteins in rheumatoid arthritis.
- To explore the potential of matricellular proteins as diagnostic and therapeutic targets for RA.
Main Methods:
- Literature review of published research on matricellular proteins and rheumatoid arthritis.
Main Results:
- Matricellular proteins are involved in extracellular matrix stability and cellular interactions.
- These proteins have demonstrated both pro- and anti-inflammatory roles in RA.
- Matricellular proteins may influence other RA disease propagation processes.
Conclusions:
- Matricellular proteins play a multifaceted role in rheumatoid arthritis.
- Understanding these roles could lead to novel diagnostic markers and therapeutic interventions for RA.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway
Role of Matrix Metalloproteases in Degradation of ECM
Rheumatic Heart Disease I: Introduction
Extracellular Matrix
Mesenchymal Stem Cells

